Dynavax Technologies | Spese Operative



Operating Expenses Cambiamento Data
AbbVie USD 9.61B 6.98B 2025-03
Adma Biologics USD 80.47M 268K 2024-12
Amgen USD 6.86B 85M 2025-03
AstraZeneca USD 10.95B 1.04B 2025-06
Biogen USD 2.12B 106.5M 2025-03
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Dynavax Technologies USD 91.79M 18.13M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Merck USD 9.44B 217M 2025-06
Neurocrine Biosciences USD 548.9M 63.2M 2025-03
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 10.05B 8.12B 2025-03
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
TG Therapeutics USD 78.24M 6.79M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12


Dynavax Technologies Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.